For personal use only
24 February 2022
ASX RELEASE
Atlas Arteria Investor Reference Pack for the year ended 31 December 2021
Atlas Arteria (ASX:ALX) is pleased to release the attached Investor Reference Pack for the year ended 31 December 2021.
____________________________________________________________________________________
For further information please contact:
Investors: | Media: |
Chloe Ranicar | Lisa Keenan |
Manager, Investor Relations | Nightingale Advisors |
+61 (0) 448 044 566 | +61 (0) 409 150 771 |
investors@atlasarteria.com | lisa@nightingaleadvisors.com.au |
____________________________________________________________________________________
This announcement has been authorised for release by the Boards of Atlas Arteria Limited and Atlas Arteria International Limited.
About Atlas Arteria
Atlas Arteria (ASX:ALX) is a global owner, operator and developer of toll roads, creating value for our investors over the long-term through considered and disciplined management. The roads we own, operate and develop benefit communities through reduced travel time, greater time certainty, reduced fuel consumption and carbon emissions.
Today the Atlas Arteria Group consists of four businesses. We currently own a 31.14% interest in the APRR toll road group in France. Adjacent to the APRR business is the smaller ADELAC business which connects to APRR in south-east France. Together APRR and ADELAC comprise a 2,318km motorway network located in the East and South East of France. In the US, we have 100% of the economic interest in the Dulles Greenway, a 22km toll road in the Commonwealth of Virginia. In Germany, we own 100% of the Warnow Tunnel in the north-east city of Rostock.
www.atlasarteria.com
Atlas Arteria Limited | Atlas Arteria International Limited |
ACN 141 075 201 | EC43828 |
Level 1, 180 Flinders Street, MELBOURNE 3000 | 4th Floor, Cedar House, 41 Cedar Avenue |
Hamilton HM12 BERMUDA |
For personal use only
INVESTOR REFERENCE PACK
31 DECEMBER 2021
Table of contents
Overview of operations
Business portfolio
Corporate structure
1 Corporate cash flow
2 Business overview and performance only2.1 APRR and AREA
2.2 ADELAC
2.3 Dulles Greenway
2.4 Warnow Tunnel
Important information
2
2
3
4
5
5
9
11
15
Disclaimer
useThe information in this presentation is given in good faith and derived from sources believed to be accurate at this date but no representation (express or implied) or warranty of accuracy, completeness or reliability is given and no responsibility or liability arising in any other way, including for errors or omission, is accepted by Atlas Arteria and its related entities, or their respective officers, including without limitation any liability from fault or negligence. The material contained in this presentation may include information derived from publicly available sources that have not been independently verified.
This presentation is not an offer or invitation for subscription or purchase of, or a recommendation of, securities. It does not take into account the investment objectives, financial situation and particular needs of the investor. Information in this presentation should not be considered as
personalF rward Looking Statements
dvice or a recommendation to investors or potential investors. Before
m king an investment in Atlas Arteria, the investor or prospective investor should consider whether such an investment is appropriate to their particular investment needs, objectives and financial circumstances
a d consult an investment adviser if appropriate.
I vestments in Atlas Arteria are subject to investment risk, including p ssible delays in repayment and loss of income and capital invested.
This presentation may contain forward-looking statements including tatements with respect to Atlas Arteria's future performance. Such forward-looking statements are not guarantees of future performance. Due care and attention have been exercised in the preparation of
fo ward-looking statements, however actual results may vary as a esult of various factors. When used in this presentation, the words, 'plan', 'will', 'may', 'should', and similar expressions are intended to id ntify forward looking statements.
Non-IFRS information
This presentation includes certain financial measures that are not recognised under Australian Accounting Standards (AAS) or International Financial Reporting Standards (IFRS). Such non-IFRS financial measures do not have a standardised meaning prescribed by AAS or IFRS and may not be comparable to similarly titled measures presented by other entities, and should not be construed as an
Foralternative to other financial measures determined in accordance with AAS or IFRS. Recipients are cautioned not to place undue reliance
n any non-IFRS financial measures included in this presentation. The non-IFRS information has not been subject to audit or review by the Company's external auditor.
No Offer
This presentation does not constitute an offer to sell, or the solicitation of an offer to buy, any securities in the United States or any other jurisdiction. Atlas Arteria's securities have not been, and will not be, registered under the US Securities Act of 1933, as amended (US Securities Act) or the securities laws of any state or other jurisdiction of the United States or elsewhere. Accordingly, Atlas Arteria's securities may not be offered
or sold, directly or indirectly, in the United States unless they are offered or sold pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and any other applicable US state securities laws.
US Ownership Restrictions
Atlas Arteria's securities are subject to ownership restrictions that apply to residents of the United States and other US persons who are not 'qualified purchasers' (as defined in Section 2(a)(51) of the US Investment Company Act of 1940). For further details, please see our website https://atlasarteria.com/stores/_sharedfiles/US_Ownership/AtlasArteria- USownershiprestrictions.pdf
PURPOSE AND
STRUCTURE
THE PURPOSE OF THE INVESTOR REFERENCE PACK only(THE 'IRP' OR THE 'PACK') IS TO PROVIDE INFORMATION SUPPLEMENTARY TO THE FINANCIAL REPORT OF
ATLAS ARTERIA FOR THE YEAR ENDED 31 DECEMBER 2021.
This Pack provides a more detailed analysis of the performance of each business within the Atlas Arteria portfolio.
useThis Pack is prepared on a different basis from the Atlas Arteria Financial Report, which is pr pared in accordance with Australian Accounting Standards. The information contained in this Pack does not and cannot be expected to provide as full an understanding of the financial performance, financial position and cash flows of Atlas Arteria for the year as in the Financial Report. This Pack should be read in conjunction with the Financial Report which is available on the Atlas Arteria website.
personalFor
ATLAS ARTERIA INVESTOR REFERENCE PACK - 31 DECEMBER 2021 | 1
Atlas Arteria International Limited
Atlas Arteria Limited
OVERVIEW OF OPERATIONS
The map below shows the locations of Atlas Arteria's operations as at 31 December 2021.
only | Virginia, United States | Luxembourg | |||||||||||
Dulles Greenway | European HQ | ||||||||||||
Rostock, Germany | |||||||||||||
use | Warnow Tunnel | France | |||||||||||
personal | APRR/ADELAC | ||||||||||||
Bermuda | Australia | ||||||||||||
ATLIX Board | Global Corporate HQ | ||||||||||||
ATLAX Board | |||||||||||||
BUSINESS PORTFOLIO | |||||||||||||
Table 1 - Atlas Arteria's portfolio of businesses and percentage interests as at 31 December 2021 | |||||||||||||
Asset | Reporting currency | Date of concession end | Economic interest | ||||||||||
For | |||||||||||||
APRR/AREA | € | November 2035 (APRR) | 31.14% | ||||||||||
September 2036 (AREA) | |||||||||||||
ADELAC | € | December 2060 | 31.17% | ||||||||||
Dulles Greenway | US$ | February 2056 | 100.00% | ||||||||||
Warnow Tunnel | € | September 2053 | 100.00% | ||||||||||
2 | ATLAS ARTERIA INVESTOR REFERENCE PACK - 31 DECEMBER 2021
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Atlas Arteria Group published this content on 23 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 February 2022 21:57:22 UTC.